In patients with chronic HCV-1 infection, recent evidences indicate that determination of a dinucleotide polymorphism (ss469415590, ΔG/TT) of a new gene, designated IFN λ-4, might be more accurate than the 12979860CC type of the IL28B locus in predicting sustained virological response (SVR) following peg-interferon and ribavirin. In addition, combined genotyping of different SNPs of the IL28B locus was shown to help dissect patients most prone to SVR among those with rs12979860CT. We examined whether single or combined genotyping of two IL28B SNPs, rs12979860 and rs8099917, and ss469415590 variation might improve the prediction of SVR
BACKGROUND & AIMS: Genetic variations near the interferon lambda 3 gene (IFNL3, IL28B) are the most ...
Background: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor...
Single nucleotide polymorphisms (SNPs) upstream of IL28B predict the outcome of treatment in chronic...
In patients with chronic HCV-1 infection, recent evidences indicate that determination of a dinucleo...
Background & Aims: In patients with chronic HCV-1 infection, recent evidences indicate that determi...
Polymorphisms near the IL28B gene, which code for interferon (IFN)-lambda 3, predict response to peg...
Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, wit...
Previous works have documented the contribution of different IL28B-associated SNPs to spontaneous HC...
AbstractThere has been a significant increase in our understanding of the host genetic determinants ...
Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest bas...
Type I interferon IFN is used for the treatment of chronic hepatitis C virus HCV infection. Despite ...
In a recent genome-wide association study, single nucleotide polymorphisms (SNPs) located near the i...
High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome fol...
Hepatitis C virus (HCV) infects 3% of the world's population. Treatment of chronic HCV consists of a...
Host genetic factors may predict the outcome and treatment response in hepatitis C virus (HCV) infec...
BACKGROUND & AIMS: Genetic variations near the interferon lambda 3 gene (IFNL3, IL28B) are the most ...
Background: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor...
Single nucleotide polymorphisms (SNPs) upstream of IL28B predict the outcome of treatment in chronic...
In patients with chronic HCV-1 infection, recent evidences indicate that determination of a dinucleo...
Background & Aims: In patients with chronic HCV-1 infection, recent evidences indicate that determi...
Polymorphisms near the IL28B gene, which code for interferon (IFN)-lambda 3, predict response to peg...
Hepatitis C virus (HCV) infection is the most common blood-borne infection in the United States, wit...
Previous works have documented the contribution of different IL28B-associated SNPs to spontaneous HC...
AbstractThere has been a significant increase in our understanding of the host genetic determinants ...
Single nucleotide polymorphisms (SNPs) near the interleukin 28B (IL28B) region are the strongest bas...
Type I interferon IFN is used for the treatment of chronic hepatitis C virus HCV infection. Despite ...
In a recent genome-wide association study, single nucleotide polymorphisms (SNPs) located near the i...
High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome fol...
Hepatitis C virus (HCV) infects 3% of the world's population. Treatment of chronic HCV consists of a...
Host genetic factors may predict the outcome and treatment response in hepatitis C virus (HCV) infec...
BACKGROUND & AIMS: Genetic variations near the interferon lambda 3 gene (IFNL3, IL28B) are the most ...
Background: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor...
Single nucleotide polymorphisms (SNPs) upstream of IL28B predict the outcome of treatment in chronic...